Journal of Applied Toxicology 1992-10-01

Alteration of brainstem auditory evoked potentials in diethylbenzene and diacetylbenzene-treated rats.

F Gagnaire, M N Becker, J De Ceaurriz

Index: J. Appl. Toxicol. 12(5) , 343-50, (1992)

Full Text: HTML

Abstract

Male Sprague-Dawley rats were treated either with 1,2-diethylbenzene (1,2-DEB) or its putative active metabolite, 1,2-diacetylbenzene (1,2-DAB). Experimental rats and appropriate controls were examined electrophysiologically for brainstem auditory evoked potentials (BAEP). Oral administration of 1,2-DEB (75 or 100 mg kg-1 once a day, 4 days a week, for 8 weeks) and intraperitoneal injection of 1,2-DAB (10 or 15 mg kg-1 once a day, 4 days a week, for 8 weeks) produced time- and dose-dependent increases in the peak latencies of all BAEP components as well as in interpeak (I-V) differences, and a decrease in the amplitudes of all the components. The absolute and interpeak latencies recovered partially during an 8-week (1,2-DEB) or a 10-week (1,2-DAB) recovery period, whereas there were long-lasting decreases in peak amplitudes.


Related Compounds

Related Articles:

New insights into mechanisms of gamma-diketone-induced axonopathy.

2009-11-01

[Neurochem. Res. 34(11) , 1919-23, (2009)]

Axonopathy-inducing 1,2-diacetylbenzene forms adducts with motor and cytoskeletal proteins required for axonal transport.

2007-12-01

[Neurochem. Res. 32(12) , 2152-9, (2007)]

Amino acid and protein targets of 1,2-diacetylbenzene, a potent aromatic gamma-diketone that induces proximal neurofilamentous axonopathy.

2002-08-15

[Toxicol. Appl. Pharmacol. 183(1) , 55-65, (2002)]

A fluorometric assay for biotinidase.

1986-04-01

[Anal. Biochem. 154 , 282, (1986)]

Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane.

2009-02-01

[Toxicol. Sci. 107(2) , 482-9, (2009)]

More Articles...